Efficient and Specific PDGFRβ‐Targeting Dual‐Mode T 1 ‐T 2 MRI Nanoprobe for Early Diagnosis of Non‐Alcoholic Fatty Liver

images are overlaid within 1 h, accurately locating fibrotic areas and improving diagnostic speed and precision. The nanoprobe shows excellent biocompatibility and enhances early fibrosis detection in NAFLD, offering significant clinical potential for early diagnosis, prognosis, and recurrence monitoring.